Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
65,128,864
-
Shares change
-
+4,264,277
-
Total reported value, excl. options
-
$176,503,793
-
Value change
-
+$10,344,308
-
Put/Call ratio
-
153%
-
Number of buys
-
71
-
Number of sells
-
61
-
Price
-
$2.71
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2021
As of 31 Dec 2021 CLOVIS ONCOLOGY INC - COM (CLVSQ) had 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,128,864 shares of stock of the company.
Largest 10 holders included STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., Palo Alto Investors LP, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Rafferty Asset Management, LLC, NORTHERN TRUST CORP, and Ikarian Capital, LLC.
This table shows 196 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.